DataJoint Launches Agentic Layer for R&D
What happened
DataJoint has launched an agent-based AI control layer for scientific and R&D workflows. The platform is designed to provide a controlled execution environment for AI agents in regulated research fields. The company aims to enable more defensible and reproducible AI-driven research.
Why it matters
- DataJoint originated in a neuroscience lab at Baylor College of Medicine in 2009, created by founder and CTO Dimitri Yatsenko. The company, initially named Vathes LLC, was re-incorporated as DataJoint Inc. in January 2024. - The company's core offering is an open-source framework for managing scientific data pipelines, available in both Python and MATLAB. It is built on a relational data model to ensure data integrity and reproducibility in complex research workflows. - In September 2025, DataJoint announced a $4.9M seed funding round co-led by Nina Capital, Inoca Capital Partners, and Capital Factory to expand its SaaS platform into life sciences and pharmaceutical companies. - The company has significant roots in academia and is used by researchers at institutions like Johns Hopkins University, UCSF, and Harvard Medical School. It also has a history of receiving NIH grants, including a $2.1M SBIR grant in 2022 and a $3.78M grant for the "DataJoint Elements" project, which develops open-source neurophysiology data workflows. - DataJoint's platform is designed to address the challenges of managing multi-modal data in research, such as synchronizing data streams from various experimental sources like calcium imaging, electrophysiology, and pose estimation. - Prior to this new agentic layer, the company's focus was on providing a "computational database" that unifies data management with processing and analysis to create a traceable and queryable record of a research study.
Key numbers
- - DataJoint originated in a neuroscience lab at Baylor College of Medicine in 2009, created by founder and CTO Dimitri Yatsenko.
- In September 2025, DataJoint announced a $4.9M seed funding round co-led by Nina Capital, Inoca Capital Partners, and Capital Factory to expand its SaaS platform into life sciences and pharmaceutical companies.
- It also has a history of receiving NIH grants, including a $2.1M SBIR grant in 2022 and a $3.78M grant for the "DataJoint Elements" project, which develops open-source neurophysiology data workflows.
What happens next
- In September 2025, DataJoint announced a $4.9M seed funding round co-led by Nina Capital, Inoca Capital Partners, and Capital Factory to expand its SaaS platform into life sciences and pharmaceutical companies.
- The company aims to enable more defensible and reproducible AI-driven research.
Quick answers
What happened in DataJoint Launches Agentic Layer for R&D?
DataJoint has launched an agent-based AI control layer for scientific and R&D workflows. The platform is designed to provide a controlled execution environment for AI agents in regulated research fields. The company aims to enable more defensible and reproducible AI-driven research.
Why does DataJoint Launches Agentic Layer for R&D matter?
DataJoint originated in a neuroscience lab at Baylor College of Medicine in 2009, created by founder and CTO Dimitri Yatsenko. The company, initially named Vathes LLC, was re-incorporated as DataJoint Inc. in January 2024. The company's core offering is an open-source framework for managing scientific data pipelines, available in both Python and MATLAB. It is built on a relational data model to ensure data integrity and reproducibility in complex research workflows. In September 2025, DataJoint announced a $4.9M seed funding round co-led by Nina Capital, Inoca Capital Partners, and Capital Factory to expand its SaaS platform into life sciences and pharmaceutical companies. The company has significant roots in academia and is used by researchers at institutions like Johns Hopkins University, UCSF, and Harvard Medical School. It also has a history of receiving NIH grants, including a $2.1M SBIR grant in 2022 and a $3.78M grant for the "DataJoint Elements" project, which develops open-source neurophysiology data workflows. DataJoint's platform is designed to address the challenges of managing multi-modal data in research, such as synchronizing data streams from various experimental sources like calcium imaging, electrophysiology, and pose estimation. Prior to this new agentic layer, the company's focus was on providing a "computational database" that unifies data management with processing and analysis to create a traceable and queryable record of a research study.
